↧
Time Isn’t on Valeant’s Side in Allergan Bid
↧
Responding to critics, Valeant CEO says company can grow organically
↧
↧
Allergan, Actavis Top Big Cap Pharmas Amid M&A Flurry
Investors.com
↧
The Race To The Market: Anacor and Valeant
Motley Fool
↧
Drug-maker Valeant begins exchange offer for Allergan
Yahoo/Reuters
↧
↧
The Case For and Against Valeant Pharmaceuticals
Motley Fool
↧
Will Allergan scramble for Shire to beat off Valeant's hostile advance?
↧
Allergan Should Buy Perrigo For A Tax Inversion; Before Someone Else Does
↧
Allergan advises shareholders against Valeant tender offer
↧
↧
Allergan, Valeant trade rapid-fire salvos in ongoing takeover battle
↧
Biotech Stocks to Watch Today: Agenus, Allergan and Auxilium Pharmaceuticals
↧
U.S. Senators Seek Review for Hostile Bid on Allergan
↧
Allergan says U.S. FDA sent 2nd letter on acute migraine treatment
↧
↧
DEALTALK-Allergan readies defense as it fights Valeant for votes
↧
Allergan readies defense as it fights Valeant for votes
Yahoo/Reuters
↧
Investor Ackman hires Credit Suisse for Allergan bid -source
↧
Ackman proposes new slate of Allergan directors amid takeover war
↧
↧
Allergan Said to Plan Cost Cuts Amid Valeant Defense
↧
How Will Allergan (AGN) Stock React To New Restructuring Plan?
↧
[video] Allergan CEO comes out swinging
↧